Cardiorespiratory Assessment and Quality of Life After Surgical Correction of Congenital Wall Malformations
HeartSoar
2 other identifiers
interventional
43
1 country
1
Brief Summary
The main objective of this study is to characterize the cardiorespiratory functional gain in patients with pectus excavatum following corrective surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Dec 2018
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 4, 2018
CompletedFirst Posted
Study publicly available on registry
December 10, 2018
CompletedStudy Start
First participant enrolled
December 16, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2024
CompletedSeptember 30, 2025
September 1, 2025
5 years
December 4, 2018
September 24, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Change in: Oxygen pulse (mL O2 / heart beat)
Recorded during incremental exercise testing.
post-op (expected maximum of 4 years) versus pre-op (approximately month -1 up to day 0))
Secondary Outcomes (33)
Change in: Body mass index (kg/m^2)
post-op (expected maximum of 4 years) versus pre-op (approximately month -1 up to day 0))
Change in: The presence/absence of dyspnea during exercise
post-op (expected maximum of 4 years) versus pre-op (approximately month -1 up to day 0))
Change in: The presence/absence of palpitations
post-op (expected maximum of 4 years) versus pre-op (approximately month -1 up to day 0))
Change in: The presence/absence of psychosocial impact
post-op (expected maximum of 4 years) versus pre-op (approximately month -1 up to day 0))
Change in: VO2MAX (ml/kg/min)
post-op (expected maximum of 4 years) versus pre-op (approximately month -1 up to day 0))
- +28 more secondary outcomes
Study Arms (1)
The study population
OTHERPatients included in this study have pectus excavatum. The have either already undergone corrective surgery during the four years prior to the inclusion period, or are scheduled for surgery during the inclusion period. Intervention: Surgical correction of pectus excavatum
Interventions
Surgical correction of pectus excavatum
Eligibility Criteria
You may qualify if:
- Patient with pectus excavatum
- Collection of informed written consent (patient and legal guardian, if applicable)
- Obligation of affiliation or beneficiary of a social security programme
You may not qualify if:
- Impossibility for the patient to participate in his/her next annual follow-up visit
- Absence of exercise test data AND respiratory function test data performed during the preoperative check-up
- Pregnant or lactating woman, patient unable to give consent, protected adult, vulnerable persons (according to French Health Code articles L.1121-6, L.1121-7, L.1211-8, L.1211-9)
- Subject deprived of liberty by judicial or administrative decision
- Participation of the subject in another interventional protocol
- Failure to properly inform the patient (e.g. a language barrier)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hôpital Arnaud de Villeneuve - CHU de Montpellier
Montpellier, 34295, France
Related Publications (1)
Suehs CM, Molinari N, Bourdin A, Solovei L. Change in cardiorespiratory parameters following surgical correction of pectus excavatum: protocol for the historical-prospective HeartSoar cohort. BMJ Open. 2023 Jun 15;13(6):e070891. doi: 10.1136/bmjopen-2022-070891.
PMID: 37321811DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Laurence Solovei, MD
University Hospitals of Montpellier, France
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 4, 2018
First Posted
December 10, 2018
Study Start
December 16, 2018
Primary Completion
December 31, 2023
Study Completion
December 31, 2024
Last Updated
September 30, 2025
Record last verified: 2025-09